Interestingly, this study underlined some genes, such as IGF2BP1, as a possible common driver of adenocarcinomas, and Liver X receptor activation, as a pathway upregulated in adenocarcinomas and downregulated in squamous cancers [77]. The gene discussed is IGF2BP1; the disease is adenocarcinoma.